Man Group plc Has $1.88 Million Holdings in GE HealthCare Technologies Inc. $GEHC

Man Group plc lifted its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 438.6% during the 2nd quarter, HoldingsChannel reports. The fund owned 29,300 shares of the company’s stock after purchasing an additional 23,860 shares during the period. Man Group plc’s holdings in GE HealthCare Technologies were worth $1,875,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of GEHC. Empowered Funds LLC increased its holdings in GE HealthCare Technologies by 6.1% in the 1st quarter. Empowered Funds LLC now owns 28,848 shares of the company’s stock worth $2,328,000 after purchasing an additional 1,665 shares in the last quarter. Acadian Asset Management LLC acquired a new stake in GE HealthCare Technologies during the 1st quarter worth approximately $259,000. Cresset Asset Management LLC boosted its position in GE HealthCare Technologies by 12.5% during the 2nd quarter. Cresset Asset Management LLC now owns 7,802 shares of the company’s stock worth $578,000 after buying an additional 865 shares during the period. Jump Financial LLC grew its holdings in GE HealthCare Technologies by 317.6% during the 2nd quarter. Jump Financial LLC now owns 28,132 shares of the company’s stock worth $2,084,000 after acquiring an additional 21,396 shares during the last quarter. Finally, Gamco Investors INC. ET AL grew its holdings in GE HealthCare Technologies by 8.6% during the 2nd quarter. Gamco Investors INC. ET AL now owns 4,041 shares of the company’s stock worth $299,000 after acquiring an additional 320 shares during the last quarter. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Price Performance

GE HealthCare Technologies stock opened at $70.42 on Wednesday. The company has a debt-to-equity ratio of 0.92, a quick ratio of 0.97 and a current ratio of 1.26. The stock has a market capitalization of $31.81 billion, a price-to-earnings ratio of 16.15, a PEG ratio of 1.88 and a beta of 0.70. The stock’s 50 day moving average price is $68.02 and its two-hundred day moving average price is $69.14. GE HealthCare Technologies Inc. has a 52-week low of $58.75 and a 52-week high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its earnings results on Wednesday, July 29th. The company reported $1.13 earnings per share for the quarter, topping analysts’ consensus estimates of $1.04 by $0.09. GE HealthCare Technologies had a return on equity of 20.12% and a net margin of 9.33%.The company had revenue of $5.29 billion for the quarter, compared to analyst estimates of $5.26 billion. During the same period in the prior year, the firm earned $1.06 earnings per share. GE HealthCare Technologies’s revenue for the quarter was up 5.8% on a year-over-year basis. On average, equities analysts predict that GE HealthCare Technologies Inc. will post 4.93 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, August 14th. Investors of record on Friday, July 24th were given a dividend of $0.035 per share. The ex-dividend date was Friday, July 24th. This represents a $0.14 annualized dividend and a yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio is presently 3.21%.

Analyst Ratings Changes

GEHC has been the subject of several analyst reports. Royal Bank Of Canada assumed coverage on shares of GE HealthCare Technologies in a research note on Tuesday, June 23rd. They set an “outperform” rating and a $80.00 price target for the company. Argus lowered their target price on GE HealthCare Technologies from $95.00 to $80.00 and set a “buy” rating for the company in a research report on Tuesday, May 19th. Piper Sandler reaffirmed a “buy” rating on shares of GE HealthCare Technologies in a report on Wednesday, July 29th. BTIG Research reiterated a “buy” rating and issued a $79.00 price target on shares of GE HealthCare Technologies in a research report on Wednesday, August 19th. Finally, BMO Capital Markets initiated coverage on GE HealthCare Technologies in a research note on Wednesday, July 8th. They issued a “market perform” rating and a $70.00 price target for the company. Ten research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $77.73.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.